Prenetics Global (PRE) Common Equity (2021 - 2024)

Prenetics Global (PRE) has disclosed Common Equity for 4 consecutive years, with $170.4 million as the latest value for Q4 2024.

  • Quarterly Common Equity fell 17.43% to $170.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $170.4 million through Dec 2024, down 17.43% year-over-year, with the annual reading at $170.4 million for FY2024, 17.43% down from the prior year.
  • Common Equity for Q4 2024 was $170.4 million at Prenetics Global, down from $206.4 million in the prior quarter.
  • The five-year high for Common Equity was $237.1 million in Q4 2022, with the low at -$400.8 million in Q4 2021.
  • Average Common Equity over 4 years is $53.3 million, with a median of $188.4 million recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 159.15% in 2022, then decreased 17.43% in 2024.
  • Over 4 years, Common Equity stood at -$400.8 million in 2021, then surged by 159.15% to $237.1 million in 2022, then decreased by 12.95% to $206.4 million in 2023, then decreased by 17.43% to $170.4 million in 2024.
  • According to Business Quant data, Common Equity over the past three periods came in at $170.4 million, $206.4 million, and $237.1 million for Q4 2024, Q4 2023, and Q4 2022 respectively.